La Jolla Pharmaceutical Co (NASDAQ:LJPC): Kevin C. Tang’s Tang Capital Partners LP filed an amended 13D.
You can check out Tang Capital Partners LP’s latest holdings and filings here.
Please follow Tang Capital Partners LP (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Tang Capital Partners LP or update its stock holdings.
Follow Kevin C. Tang's Tang Capital Management
You can access the original SEC filing by clicking here.
Ownership Summary Table
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Tang Capital Partners | 0 | 3,620,419 | 0 | 3,620,419 | 3,620,419 | 16.3 % |
Tang Capital Management | 0 | 3,620,419 | 0 | 3,620,419 | 3,620,419 | 16.3 % |
Kevin C. Tang | 48,000 | 3,620,419 | 48,000 | 3,620,419 | 3,668,419 | 16.5% |
Page 1 of 10 – SEC Filing
La Jolla Pharmaceutical Company |
(Name of Issuer) |
Common Stock, par value $0.0001 |
(Title of Class of Securities) |
503459604 |
(CUSIP Number) |
(858) 200-3830 |
(Name, Address and Telephone Number of Person Authorized to |
Receive Notices and Communications) |
February 26, 2018 |
(Date of Event which Requires Filing of this Statement) |